Discovery of potent small molecule ubiquitin-specific protease 10 inhibitors with anti-hepatocellular carcinoma activity through regulating YAP expression

Y Lu, J Gao, P Wang, H Chen, X He, M Luo… - European Journal of …, 2024 - Elsevier
High expression of ubiquitin-specific protease 10 (USP10) promote the proliferation of
hepatocellular carcinoma (HCC), thus the development of USP10 inhibitors holds promise …

[HTML][HTML] Ubiquitin-specific protease 7 is a drug-able target that promotes hepatocellular carcinoma and chemoresistance

W Zhang, J Zhang, C Xu, S Zhang, S Bian… - Cancer Cell …, 2020 - Springer
Background Ubiquitin-specific protease 7 (USP7) is a de-ubiquitin enzyme that plays an
essential role in multiple cancers and becomes a target for treatment. However, the role of …

[HTML][HTML] Inhibiting USP8 overcomes hepatocellular carcinoma resistance via suppressing receptor tyrosine kinases

Y Zhu, J Xu, W Hu, F Wang, Y Zhou, W Gong… - Aging (Albany …, 2021 - ncbi.nlm.nih.gov
The ubiquitin-specific protease 8 (USP8) is a prototypic multidomain deubiquitinating
enzyme with pleiotropic functions. We investigated the role of USP8 in hepatocellular …

[HTML][HTML] Downregulation of USP12 inhibits tumor growth via the p38/MAPK pathway in hepatocellular carcinoma

C Liu, X Li, G Feng, M Cao, F Liu… - Molecular …, 2020 - spandidos-publications.com
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide.
Ubiquitin‑specific protease 12 (USP12) is specifically upregulated in the tumor tissues of …

Discovery of selective and potent USP22 inhibitors via structure-based virtual screening and bioassays exerting anti-tumor activity

Y Zhang, J Song, Y Zhou, H Jia, T Zhou, Y Sun… - Bioorganic …, 2023 - Elsevier
Abstract Ubiquitin-specific protease 22 (USP22) plays a prominent role in tumor
development, invasion, metastasis and immune reprogramming, which has been proposed …

The deubiquitinating enzyme USP19 facilitates hepatocellular carcinoma progression through stabilizing YAP

Z Tian, C Xu, W He, Z Lin, W Zhang, K Tao, R Ding… - Cancer Letters, 2023 - Elsevier
Hippo pathway plays a crucial role in the progression of hepatocellular carcinoma (HCC),
and yes-associated protein (YAP) is one of the major factors of the Hippo pathway. However …

Knockdown of ubiquitin‐specific peptidase 13 inhibits cell growth of hepatocellular carcinoma by reducing c‐Myc expression

J Huang, ZL Gu, W Chen, YY Xu… - The Kaohsiung Journal …, 2020 - Wiley Online Library
Abstract Ubiquitin‐specific peptidase 13 (USP13) has been reported to be involved in the
tumorigenesis of several tumors, but its function in tumors is still controversial. In this study …

Overexpression of ubiquitin-specific protease15 (USP15) promotes tumor growth and inhibits apoptosis and correlated with poor disease-free survival in …

XQ Yao, L Li, LZ Piao, GJ Zhang… - … in cancer research …, 2020 - journals.sagepub.com
USP15 is a member of ubiquitin-specific proteases (USPs, the largest subfamily of
deubiquitinases) and functions as a stabilize factor of target proteins in reversible …

USP35 promotes hepatocellular carcinoma progression by protecting PKM2 from ubiquitination‑mediated degradation

T Lv, B Zhang, C Jiang, Q Zeng… - … Journal of Oncology, 2023 - spandidos-publications.com
Hepatocellular carcinoma (HCC) is the most frequently diagnosed primary liver cancer with
a high mortality rate and imposes a huge burden on patients and society. Recently, ubiquitin …

[HTML][HTML] USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c

Y Yao, W Ma, Y Guo, Y Liu, P Xia, X Wu, Y Chen… - Oncogenesis, 2022 - nature.com
Despite of advances in treatment options, hepatocellular carcinoma (HCC) remains nearly
incurable and has been recognized as the third leading cause of cancer-related deaths …